BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

678 related articles for article (PubMed ID: 27117699)

  • 1. The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factor.
    Ajeganova S; van Steenbergen HW; Verheul MK; Forslind K; Hafström I; Toes RE; Huizinga TW; Svensson B; Trouw LA; van der Helm-van Mil AH
    Ann Rheum Dis; 2017 Jan; 76(1):112-118. PubMed ID: 27117699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI-detected osteitis is not associated with the presence or level of ACPA alone, but with the combined presence of ACPA and RF.
    Boeters DM; Nieuwenhuis WP; Verheul MK; Newsum EC; Reijnierse M; Toes RE; Trouw LA; van der Helm-van Mil AH
    Arthritis Res Ther; 2016 Aug; 18():179. PubMed ID: 27485323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the Presence of Anti-Carbamylated Protein Antibodies in Early Arthritis With a Poorer Clinical and Radiologic Outcome: Data From the French ESPOIR Cohort.
    Truchetet ME; Dublanc S; Barnetche T; Vittecoq O; Mariette X; Richez C; Blanco P; Mahler M; Contin-Bordes C; Schaeverbeke T;
    Arthritis Rheumatol; 2017 Dec; 69(12):2292-2302. PubMed ID: 28853240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-carbamylated protein (anti-CarP) antibodies precede the onset of rheumatoid arthritis.
    Shi J; van de Stadt LA; Levarht EW; Huizinga TW; Hamann D; van Schaardenburg D; Toes RE; Trouw LA
    Ann Rheum Dis; 2014 Apr; 73(4):780-3. PubMed ID: 24336334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis.
    Shi J; van de Stadt LA; Levarht EW; Huizinga TW; Toes RE; Trouw LA; van Schaardenburg D
    Arthritis Rheum; 2013 Apr; 65(4):911-5. PubMed ID: 23279976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies.
    Jiang X; Trouw LA; van Wesemael TJ; Shi J; Bengtsson C; Källberg H; Malmström V; Israelsson L; Hreggvidsdottir H; Verduijn W; Klareskog L; Alfredsson L; Huizinga TW; Toes RE; Lundberg K; van der Woude D
    Ann Rheum Dis; 2014 Oct; 73(10):1761-8. PubMed ID: 24812286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-carbamylated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients: lack of correlation with anti-cyclic citrullinated protein antibodies and rheumatoid factor.
    Alessandri C; Bartosiewicz I; Pendolino M; Mancini R; Colasanti T; Pecani A; Morello F; Mastrangelo A; Sabatinelli D; Riccieri V; Di Franco M; Ceccarelli F; Perricone C; Conti F; Valesini G
    Clin Exp Rheumatol; 2015; 33(6):824-30. PubMed ID: 26411477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of anti-CarP and anti-PAD3 antibodies alone or in combination with RF and ACPA for the severity of rheumatoid arthritis.
    Lamacchia C; Courvoisier DS; Jarlborg M; Bas S; Roux-Lombard P; Möller B; Ciurea A; Finckh A; Bentow C; Martinez-Prat L; Mahler M; Gabay C; Nissen MJ;
    Rheumatology (Oxford); 2021 Oct; 60(10):4598-4608. PubMed ID: 33502443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticarbamylated protein antibodies are associated with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the Norfolk Arthritis Register.
    Humphreys JH; Verheul MK; Barton A; MacGregor AJ; Lunt M; Toes RE; Symmons DP; Trouw LA; Verstappen SM
    Ann Rheum Dis; 2016 Jun; 75(6):1139-44. PubMed ID: 26443608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of rheumatoid factor and anti-citrullinated peptide antibody with disease progression and treatment outcomes in patients with rheumatoid arthritis.
    Katchamart W; Koolvisoot A; Aromdee E; Chiowchanwesawakit P; Muengchan C
    Rheumatol Int; 2015 Oct; 35(10):1693-9. PubMed ID: 25903353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-carbamylated Protein Antibody Levels Correlate with Anti-Sa (Citrullinated Vimentin) Antibody Levels in Rheumatoid Arthritis.
    Challener GJ; Jones JD; Pelzek AJ; Hamilton BJ; Boire G; de Brum-Fernandes AJ; Masetto A; Carrier N; Ménard HA; Silverman GJ; Rigby WFC
    J Rheumatol; 2016 Feb; 43(2):273-281. PubMed ID: 26669911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-carbamylated protein antibodies are present prior to rheumatoid arthritis and are associated with its future diagnosis.
    Gan RW; Trouw LA; Shi J; Toes RE; Huizinga TW; Demoruelle MK; Kolfenbach JR; Zerbe GO; Deane KD; Edison JD; Gilliland WR; Norris JM; Holers VM
    J Rheumatol; 2015 Apr; 42(4):572-9. PubMed ID: 25593232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Anti-Carbamylated Protein Antibodies Compared to Anti-Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First-Degree Relatives, and Healthy Controls.
    Koppejan H; Trouw LA; Sokolove J; Lahey LJ; Huizinga TJ; Smolik IA; Robinson DB; El-Gabalawy HS; Toes RE; Hitchon CA
    Arthritis Rheumatol; 2016 Sep; 68(9):2090-8. PubMed ID: 26946484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does information on novel identified autoantibodies contribute to predicting the progression from undifferentiated arthritis to rheumatoid arthritis: a study on anti-CarP antibodies as an example.
    Boeters DM; Trouw LA; van der Helm-van Mil AHM; van Steenbergen HW
    Arthritis Res Ther; 2018 May; 20(1):94. PubMed ID: 29724250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseases.
    Pecani A; Alessandri C; Spinelli FR; Priori R; Riccieri V; Di Franco M; Ceccarelli F; Colasanti T; Pendolino M; Mancini R; Truglia S; Barbati C; Vomero M; Sabatinelli D; Morello F; Valesini G; Conti F
    Arthritis Res Ther; 2016 Nov; 18(1):276. PubMed ID: 27887639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additive effect of anti-citrullinated protein antibodies and rheumatoid factor on bone erosions in patients with RA.
    Hecht C; Englbrecht M; Rech J; Schmidt S; Araujo E; Engelke K; Finzel S; Schett G
    Ann Rheum Dis; 2015 Dec; 74(12):2151-6. PubMed ID: 25115448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of autoantibodies in "seronegative" rheumatoid arthritis associates with classical risk factors and high disease activity.
    Reed E; Hedström AK; Hansson M; Mathsson-Alm L; Brynedal B; Saevarsdottir S; Cornillet M; Jakobsson PJ; Holmdahl R; Skriner K; Serre G; Alfredsson L; Rönnelid J; Lundberg K
    Arthritis Res Ther; 2020 Jul; 22(1):170. PubMed ID: 32678001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific Association of HLA-DRB1*03 With Anti-Carbamylated Protein Antibodies in Patients With Rheumatoid Arthritis.
    Regueiro C; Rodriguez-Rodriguez L; Triguero-Martinez A; Nuño L; Castaño-Nuñez AL; Villalva A; Perez-Pampin E; Lopez-Golan Y; Abasolo L; Ortiz AM; Herranz E; Pascual-Salcedo D; Martínez-Feito A; Boveda MD; Gomez-Reino JJ; Martín J; Gonzalez-Escribano MF; Fernandez-Gutierrez B; Balsa A; Gonzalez-Alvaro I; Gonzalez A
    Arthritis Rheumatol; 2019 Mar; 71(3):331-339. PubMed ID: 30277011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking is associated with the concurrent presence of multiple autoantibodies in rheumatoid arthritis rather than with anti-citrullinated protein antibodies per se: a multicenter cohort study.
    van Wesemael TJ; Ajeganova S; Humphreys J; Terao C; Muhammad A; Symmons DP; MacGregor AJ; Hafström I; Trouw LA; van der Helm-van Mil AH; Huizinga TW; Mimori T; Toes RE; Matsuda F; Svensson B; Verstappen SM; van der Woude D
    Arthritis Res Ther; 2016 Dec; 18(1):285. PubMed ID: 27906045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Only rheumatoid factor-positive subset of anti-citrullinated peptide/protein antibody-negative rheumatoid arthritis may seroconvert to anti-citrullinated peptide/protein antibody-positive.
    Hiwa R; Ohmura K; Nakabo S; Terao C; Murakami K; Nakashima R; Imura Y; Yukawa N; Yoshifuji H; Hashimoto M; Furu M; Ito H; Fujii T; Mimori T
    Int J Rheum Dis; 2017 Jun; 20(6):731-736. PubMed ID: 28198158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.